FederalHR1285directIntroduced

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Introduced
Adopted by House

Overview

This resolution expresses the House's position that mifepristone (the abortion pill) is safe and should be accessible based on scientific evidence, opposing restrictions on medication abortion.

Why it matters: Christian families who believe life begins at conception are directly affected by policies governing abortion access; this resolution advocates for expanded abortion availability, which conflicts with pro-life convictions held by many Christian families.

Topic: Sanctity of life · classifier confidence 95%

What this changes

Other

Law today: The bill does not spell out the prior law. It references current law and policy governing mifepristone (a medication used to end pregnancy) but does not detail specific statutes or regulations.

If passed: This is a non-binding resolution expressing the House's view that mifepristone access should be based on scientific evidence and made more equitable and transparent. It does not change law directly, but advocates for policy alignment with research supporting mifepristone's safety and efficacy. If adopted, it would signal congressional intent that regulations on abortion medication should reflect peer-reviewed science rather than other considerations.

AI-generated from the bill text — verify against the official text.

Likely supporters & opponents

Likely support

abortion-access advocacy organizations — Mifepristone has a strong safety record supported by decades of research and should not be restricted by law based on political or moral objections.
medical and public-health organizations — Evidence-based medicine and transparent policy serving patients' health should guide medication regulation, not ideology.

Likely opposition

pro-life organizations and advocates — Mifepristone ends the life of an unborn child, and promoting its access contradicts the moral and legal protection of unborn life regardless of scientific claims about the drug's safety to the pregnant woman.

AI-inferred typical positions based on the bill’s substance — general stakeholder categories, not confirmed endorsements.

Should I support this?

Likely harmful for Christian families

This resolution advocates for expanded access to medication that ends pregnancy, which conflicts with Christian convictions about the sanctity of unborn life. Although framed as a scientific matter, the resolution's practical effect would be to encourage removal of legal and policy barriers to abortion, directly opposing Christian pro-life values.

An AI assessment from a Christian-family perspective — religious freedom, parental rights, and freedom in education — not legal or voting advice.

💬 Chat about this bill ↗Official bill text ↗View on LegiScan ↗

Official summary

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Status timeline

2026-05-14Referred to the House Committee on Energy and Commerce.H
2026-05-14Submitted in HouseH

H = House · S = Senate · A = Assembly